Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.

NCT06812104

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Kameda General Hospital Kamogawa, Chiba, Japan
  • University of Fukui Hospital Yoshida, Fukui, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View all 17 locations
View Trial Details
Recruiting

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

NCT05958121

Conditions
Cancer, Disease Attributes, Neoplasms, +6 more
Locations
  • Universitaetsklinikum Heidelberg AöR Heidelberg, Baden-Wurttemberg, Germany
  • Thoraxklinik Heidelberg gGmbH Heidelberg, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Mannheim GmbH Mannheim, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Tuebingen AöR Tübingen, Baden-Wurttemberg, Germany
View all 29 locations
View Trial Details
Recruiting

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT07123454

Conditions
B-Cell Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Irvine, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site New York, United States
View all 22 locations
View Trial Details
Recruiting

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

NCT06802315

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult, Bone Marrow Diseases, +17 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
View Trial Details
Recruiting

A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)

NCT06189391

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Fifth Medical Center of PLA General Hospital ( Site 0005) Beijing, Beijing Municipality, China
  • Beijing Cancer hospital ( Site 0001) Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University ( Site 0011) Xiameng, Fujian, China
  • Sun Yat-Sen University Cancer Center ( Site 0003) Guangzhou, Guangdong, China
View all 15 locations
View Trial Details

Related conditions